Departments of Medical Microbiology, Radboud University Nijmegen Medical Center, 6500 HB, Nijmegen, The Netherlands.
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7862-7. doi: 10.1073/pnas.1220360110. Epub 2013 Apr 18.
Volunteers immunized under chloroquine chemoprophylaxis with Plasmodium falciparum sporozoites (CPS) develop complete, long-lasting protection against homologous sporozoite challenge. Chloroquine affects neither sporozoites nor liver-stages, but kills only asexual forms in erythrocytes once released from the liver into the circulation. Consequently, CPS immunization exposes the host to antigens from both preerythrocytic and blood stages, and induced immunity might target either of these stages. We therefore explored the life cycle stage specificity of CPS-induced protection. Twenty-five malaria-naïve volunteers were enrolled in a clinical trial, 15 of whom received CPS immunization. Five immunized subjects and five controls received a sporozoite challenge by mosquito bites, whereas nine immunized and five control subjects received an i.v. challenge with P. falciparum-infected erythrocytes. The latter approach completely bypasses preerythrocytic stages, enabling a direct comparison of protection against either life cycle stage. CPS-immunized subjects (13 of 14) developed anticircumsporozoite antibodies, whereas only one volunteer generated minimal titers against typical blood-stage antigens. IgG from CPS-immunized volunteers did not inhibit asexual blood-stage growth in vitro. All CPS-immunized subjects (5 of 5) were protected against sporozoite challenge. In contrast, nine of nine CPS-immunized subjects developed parasitemia after blood-stage challenge, with identical prepatent periods and blood-stage multiplication rates compared with controls. Intravenously challenged CPS-immunized subjects showed earlier fever and increased plasma concentrations of inflammatory markers D-dimer, IFN-γ, and monokine induced by IFN-γ than i.v. challenged controls. The complete lack of protection against blood-stage challenge indicates that CPS-induced protection is mediated by immunity against preerythrocytic stages. However, evidence is presented for immune recognition of P. falciparum-infected erythrocytes, suggesting memory responses unable to generate functional immunity.
志愿者在氯喹化学预防下用疟原虫孢子(CPS)免疫,可对同源孢子挑战产生完全的、持久的保护。氯喹既不影响孢子,也不影响肝期,但一旦从肝脏释放到循环中,就只杀死红细胞中的无性期。因此,CPS 免疫使宿主暴露于来自红细胞前期和血液期的抗原,诱导的免疫可能针对这两个阶段之一。因此,我们探讨了 CPS 诱导的保护的生命周期阶段特异性。25 名疟原虫-naive 志愿者参加了一项临床试验,其中 15 名接受了 CPS 免疫。5 名免疫受试者和 5 名对照者接受了蚊子叮咬的孢子挑战,而 9 名免疫和 5 名对照者接受了静脉内感染疟原虫感染的红细胞的挑战。后一种方法完全绕过红细胞前期阶段,能够直接比较对任何一个生命阶段的保护。CPS 免疫的受试者(14 名中的 13 名)产生了抗环子孢子蛋白抗体,而只有 1 名志愿者产生了针对典型血液期抗原的最小滴度。CPS 免疫的志愿者的 IgG 不能抑制体外无性血期生长。所有 CPS 免疫的受试者(5 名中的 5 名)均免受孢子挑战的保护。相比之下,在血液期挑战后,9 名 CPS 免疫的受试者中有 9 名发生了疟疾,与对照组相比,潜伏前期和血液期倍增率相同。静脉内接受挑战的 CPS 免疫的受试者的发热较早,血浆中促炎标志物 D-二聚体、IFN-γ和 IFN-γ诱导的单核细胞的浓度增加。对血液期挑战完全缺乏保护表明,CPS 诱导的保护是由针对红细胞前期阶段的免疫介导的。然而,有证据表明对疟原虫感染的红细胞的免疫识别,表明记忆反应不能产生功能性免疫。